The Patent Finder
US

Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same

US 10,765,726 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jun 10, 2030 · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 9,056,106), so the cap could be lower.

Filed Dec 6, 2017 as application 15/833,520 · Granted Sep 8, 2020
Base term, 20 years from filing · capped by a resolved terminal disclaimer
Today
20 years from filing
2010 2030
Clock starts
Jul 14, 2010
Term ends
Jun 10, 2030
Granted
Sep 8, 2020
base term after the term ends fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,153,590, US 9,056,106.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 14, 2010, when application 12/836,536, the earliest non-provisional in its chain, was filed (this one was filed Dec 6, 2017)Jul 14, 2030High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,153,590, US 9,056,106)capped to Jun 10, 2030Medium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJun 10, 2030Medium confidence

This family

US 9,056,106In force
no later than Jul 2032
no later than Jul 2032
Application 14/320,199Abandoned
not computed
not computed
Application 15/212,105Abandoned
not computed
not computed
US 10,765,726this patent
Jun 2030
Jun 2030
Application 16/943,933Abandoned
not computed
not computed
Application 17/569,402Abandoned
not computed
not computed
Application 18/352,637Abandoned
not computed
not computed
Application 18/909,369Pending
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 25, 2018
Reel 44733, frame 428
Sinha, Uma; Lu, Genmin; Hutchaleelaha, Athiwat; Hollenbach, Stanley J.Portola Pharmaceuticals, Inc.Assignment of Assignor's Interest
Mar 18, 2019
Reel 48633, frame 673
Portola Pharmaceuticals, Inc.HCR Collateral Management, LLCSecurity Interest
Jul 2, 2020
Reel 53120, frame 925
HCR Collateral Management, LLCPortola Pharmaceuticals, Inc.Release of Security Interest
Jan 7, 2021
Reel 54920, frame 739
Portola Pharmaceuticals, Inc.Portola Pharmaceuticals, LLCChange of Name
Jan 7, 2021
Reel 54921, frame 131
Portola Pharmaceuticals, LLCAlexion Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jan 7, 2021
Reel 54922, frame 857
Alexion Pharma International Operations Unlimited CompanyAlexion Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jul 21, 2022
Reel 60799, frame 729
Alexion Pharmaceuticals, Inc.Alexion Pharma International Operations Unlimited CompanyAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited